Browsing by Author Giralt Lledó, Ernest

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 35 to 54 of 68 < previous   next >
Issue DateTitleAuthor(s)
13-Jul-2009Exploration of the one-bead one-compound methodology for the design of prolyl oligopeptidase substratesComellas, Gemma; Kaczmarska, Zuzanna; Tarragó Clua, Maria Teresa; Teixidó Turà, Meritxell; Giralt Lledó, Ernest
18-May-2015From bee venom to blood-brain barrier shuttles. Development of minimized apamin derivatives for brain delivery of antibodies and other cargoesOller Salvia, Benjamí
7-Mar-2018From phage display and venoms to protease-resistant peptides: Design of BBB-shuttles and peptides targeting EGFDíaz Perlas, Cristina
18-Dec-2018HAI Peptide and Backbone Analogs-Validation and Enhancement of Biostability and Bioactivity of BBB ShuttlesArranz Gibert, Pol; Prades, Roger; Guixer, Bernat; Guerrero, Simón; Araya, Eyleen; Ciudad Fernández, Sonia; Kogan, Marcelo J.; Giralt Lledó, Ernest; Teixidó Turà, Meritxell
24-Nov-2008Identificació de proteases mitjançant proteòmica basada en activitat.Sabidó Aguadé, Eduard
24-Apr-2018Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptidesArranz Gibert, Pol; Ciudad Fernández, Sonia; Seco Moral, Jesús; García Arroyo, Jesús; Giralt Lledó, Ernest; Teixidó Turà, Meritxell
2015Inhibition of human prolyl oligopeptidase activity by the Cyclotide Psysol 2 isolated from Psychotria solitudinumHellinger, Roland; Koehbach, Johannes; Puigpinós, Albert; Clark, Richard J.; Tarragó Clua, Maria Teresa; Giralt Lledó, Ernest; Gruber, Christian W.
2012Inorganic Nanoparticles and the Immune System: Detection, Selective Activation and ToleranceGómez i Bastús, Neus; Sánchez Tilló, Ester; Pujals Riatós, Silvia; Comenge, Joan; Giralt Lledó, Ernest; Celada Cotarelo, Antonio; Lloberas Cavero, Jorge; Puntes, Víctor
17-Jul-2017Jumping Hurdles: Peptides Able To Overcome Biological BarriersSánchez Navarro, Macarena; Teixidó Turà, Meritxell; Giralt Lledó, Ernest
5-Jan-2016MiniAp-4: A Venom-Inspired Peptidomimetic for Brain DeliveryOller Salvia, Benjamí; Sánchez Navarro, Macarena; Ciudad Fernández, Sonia; Guiu, Marc; Arranz Gibert, Pol; García, Cristina; Gomis i Cabré, Roger; Cecchelli, Roméo; García Arroyo, Jesús; Giralt Lledó, Ernest; Teixidó Turà, Meritxell
15-Apr-2013Molecular recognition in gas phase: theoretical and experimental study of non-covalent protein-ligand complexes by mass-spectrometryDyachenko, Andrey
18-Nov-2015N-Myristoylation-Dependent c-Src InteractionsLe Roux, Anabel-Lise
4-Jul-2016New strategies based on nanosystems to facilitate the crossing through biological barriersGarcia Garcia, Josep
5-Oct-2006NMR in drug discovery. From screening to structure-based design of antitumoral agentsRodríguez Mías, Ricard Aleix
3-May-2004Nueva estrategia de química combinatoria para el diseño y modificación de dominios proteicos, UnaPastor Porras, José Javier
2017Obrint portes: com fer arribar nous fàrmacs al cervell : lliçó inaugural del curs acadèmic 2017-2018Giralt Lledó, Ernest
2020Photoswitchable dynasore analogs to control endocytosis with lightCamarero, Núria; Trapero, Ana; Pérez Jiménez, Ariadna; Macia, Eric; Gomila Juaneda, Alexandre; Gorostiza Langa, Pablo Ignacio; Nevola, Laura; Llobet Berenguer, Artur, 1972-; Llebaria, Amadeu; Hernando, Jordi; Giralt Lledó, Ernest
26-Jun-2020Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon ResonanceGuardiola Bagán, Salvador; Varese, Monica; Taulés i Marín, Marta; Díaz Lobo, Mireia; García Arroyo, Jesús; Giralt Lledó, Ernest
6-Jun-2014Protease inhibitors as therapeutic agentsMendieta Martínez, Laura
1-Apr-2022Proteomic tools for the quantitative analysis of artificial peptide libraries: detection and characterization of target-amplified PD-1 inhibitorsGay i Marín, Marina; Díaz Lobo, Mireia; Gusi Vives, Mar; Arauz-Garofalo, Gianluca; Vilanova, Mar; Giralt Lledó, Ernest; Vilaseca, Marta; Guardiola Bagán, Salvador